Rigda, Rachael S.
National Health and Medical Research Council · The University of Adelaide
3 papers on CoChat
Most cited papers
- Verified
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: A randomized controlled trial
Thazhath, S. S., Marathe, C. S., Wu, T., Chang, J., Khoo, J., Kuo, P., Checklin, H. L., Bound, M. J., Rigda, R. S., Crouch, B., et al. (2016) · Diabetes
Diabetes Treatment and ManagementGastrointestinal motility and disorders
Cited by 83
- Verified
Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes
Jones, K. L., Rigda, R. S., Buttfield, M. D. M., Hatzinikolas, S., Pham, H. T., Marathe, C. S., Wu, T., Lange, K., Trahair, L. G., Rayner, C. K., et al. (2019) · Diabetes, Obesity and Metabolism
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 66
- Verified
Effect of hyperglycemia on triggering of transient lower esophageal sphincter relaxations
Zhang, Q., Horowitz, M., Rigda, R., Rayner, C., Worynski, A., & Holloway, R. H. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology
Gastroesophageal reflux and treatmentsGastrointestinal motility and disorders
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free